Overview
Status
Active
Registry date
2016-06-27
Share capital
5,000.00 PLN
Registered address
ul. Bonifraterska 17, 00-203 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 181 days for 2025).
- 202513/10/2026
- 202405/08/2025
- 202326/03/2024
- 202230/03/2023
- 202117/01/2022
- 202002/08/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 6.18mMedianUSD 895.43kAverageUSD 9.80m
Net profit
This companyUSD -248.08kMedianUSD 19.07kAverageUSD 341.02k
Operating costs
This companyUSD 5.81mMedianUSD 832.62kAverageUSD 8.90m
Assets
This companyUSD 3.67mMedianUSD 474.63kAverageUSD 5.34m
Industry
Trademarks
SBM Life Science currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2020.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| EASY HERBS | Z.510727 | 1, 31 | Proceedings discontinued | – | |
| EASY SALAD | Z.510728 | 1, 31 | Proceedings discontinued | – |
| Mark | Protected until | |
|---|---|---|
| EASY HERBS | – | |
| EASY SALAD | – |
Authorized Representatives
Alexandre Pierre Simmler – Management Board Member
Manner of representation
Each member of the management board is authorized to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sbm Jardin | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-07-01.
14 1940 1210 0103 6240 0010 0000
62 1940 1210 0103 6240 0011 0000
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 16,901PLN 16,901 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 28, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Chem4polsp. z o.o. | $6,926,177.18 | chem4pol.pl | ||
| Bestpharmasp. z o.o. | $5,786,190.68 | bestpharma.pl | ||
| Bioagrissp. z o.o. + limited partnership | $4,501,289.17 | bioagris.pl | ||
| Ormeasp. z o.o. | $3,816,696.50 | ormea.pl | ||
| Chemix Groupsp. z o.o. | $3,489,223.26 | chemixgroup.pl | ||
| Grafia K. Dziewulskasp. j. | $3,297,814.71 | grafia.waw.pl | ||
| Grosschemsp. z o.o. | $3,144,284.08 | grosschem.pl | ||
| Killgerm Polskasp. z o.o. | $3,127,569.65 | killgerm.pl | ||
| Medicossp. z o.o. | $2,712,576.27 | medicos.com.pl | ||
| Sterilcosp. z o.o. | $2,656,361.06 | sterilco.pl |
Change history
| Date | Event | |
|---|---|---|
| 2016-10-12 | Address change (Ul. Krucza 16/22, 00-526, Warszawa → Ul. Bonifraterska 17, 00-203, Warszawa) | |
| 2016-06-27 | Entered in the register |
FAQ
The main business activity of SBM Life Science focuses on wholesale of chemical products.
The company was registered in the Polish National Court Register (KRS) on June 27, 2016.
The headquarters is located at: ul. Bonifraterska 17, 00-203 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from October 1, 2024 to September 30, 2025.
In 2025, the company generated total revenue of USD 6,179,969, representing an increase of 66.2% compared to 2024.
No, the company recorded a net loss of USD 248,082 in 2025. For comparison, in 2024 the loss was USD 21,776, representing a multi-fold increase in the loss compared to 2024.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 3,304,496 in 2025, representing 57% of all operating expenses.
Last updated: 2026-10-13